NES
DGX icon

New England Securities’s Quest Diagnostics DGX Stock Holding History

New England Securities’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$35K Buy
523
+362
+225% +$22.8K 0.01% 687
2014
Q3 		$10K Buy
+161
New +$9.92K ﹤0.01% 1094

Other funds holding DGX

LTI
Laffer Tengler Investments Nashville, Tennessee $677M AUM 27.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

New England Securities's DGX Position: Q4 2014 in Review

New England Securities increased its Quest Diagnostics (DGX) stake by 225% in Q4 2014, buying an estimated $22.8K and bringing the position to 523 shares worth $35K. The position accounts for 0.01% of the portfolio, ranked #687.

New England Securities first reported a position in DGX in Q3 2014 and has held it in 2 quarters since. 517 funds tracked by Wall St. Rank hold DGX as of Q4 2014.

  • New England Securities held 523 shares of Quest Diagnostics worth $35K as of Q4 2014.
  • New England Securities bought 362 Quest Diagnostics shares in Q4 2014, an estimated $22.8K.
  • Quest Diagnostics made up 0.01% of New England Securities's portfolio in Q4 2014, its #687 holding.
  • New England Securities first reported a position in Quest Diagnostics in Q3 2014 and has held it in 2 quarters since.
  • 517 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.